ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 6, 2006, Pages

  Godeny, Michael D ^a   Sayeski, Peter P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Ribosomal S6 kinase; SL0101

Indexed keywords

ANGIOTENSIN II; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN C FOS; PROTEIN KINASE C ZETA; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; RIBOSOMAL S6 KINASE 2; RIBOSOMAL S6 KINASE INHIBITOR; S6 KINASE; SERUM RESPONSE FACTOR; SL 0101; TRANSCRIPTION FACTOR ELK 1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; NONHUMAN; ONCOGENE C FOS; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RIBOSOME;

ANGIOTENSIN II; ANIMALS; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CRICETINAE; CYTOPLASM; ENZYME ACTIVATION; ENZYME INHIBITORS; ETS-DOMAIN PROTEIN ELK-1; HETEROTRIMERIC GTP-BINDING PROTEINS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-FYN; PROTO-ONCOGENE PROTEINS C-YES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, ANGIOTENSIN, TYPE 1; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION;

EID: 33845312299     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00618.2005     Document Type: Article

References (34)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, and Struhl K. Current Protocols in Molecular Biology. New York: Wiley, 1995.
2. Chen RH, Sarnecki C, and Blenis J. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 12: 915-927, 1992.
3. Clark DE, Errington TM, Smith JA, Frierson HF Jr,. Weber MJ, and Lannigan DA. The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res 65: 3108-3116, 2005.
4. Deshayes F and Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 16: 293-299, 2005.
5. Doan TN, Ali MS, and Bernstein KE. Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling. J Biol Chem 276: 20954-20958, 2001.
6. Frodin M and Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151: 65-77, 1999.
7. Godeny MD and Sayeski PP. ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCζ-controlled ERK1/2 activity within the nucleus. Am J Physiol Cell Physiol 291: C1297-C1307, 2006.
8. Hsiao KM, Chou SY, Shih SJ, and Ferrell JE Jr. Evidence that inactive p42 mitogen-activated protein kinase and inactive Rsk exist as a heterodimer in vivo. Proc Natl Acad Sci USA 91: 5480-5484, 1994.
9. Ishida M, Ishida T, Thomas SM, and Berk BC. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 82: 7-12, 1998.
10. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, and Berk BC. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 77: 1053-1059, 1995.
11. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, and Thomas G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 16: 3693-3704, 1997.
12. Liao J, Hodge C, Meyer D, Ho PS, Rosenspire K, and Schwartz J. Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element. J Biol Chem 272: 25951-25958, 1997.
13. Maloney DJ and Hecht SM. Synthesis of a potent and selective inhibitor of p90 Rsk. Org Lett 7: 1097-1099, 2005.
14. Marais R, Wynne J, and Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-393, 1993.
15. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, and Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375: 247-250, 1995.
16. Misra RP, Rivera VM, Wang JM, Fan PD, and Greenberg ME. The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts. Mol Cell Biol 11: 4545-4554, 1991.
17. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, and Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183, 2001.
18. Sadoshima J and Izumo S. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15: 775-787, 1996.
19. 2+-dependent signaling. Circ Res 76: 1-15, 1995.
20. Sandberg EM, Ma X, VonDerLinden D, Godeny MD, and Sayeski PP. Jak2 tyrosine kinase mediates angiotensin II-dependent inactivation of ERK2 via induction of mitogen-activated protein kinase phosphatase 1. J Biol Chem 279: 1956-1967, 2004.
21. 2+, and protein kinase C. Circ Res 82: 1279-1288, 1998.
22. Scimeca JC, Nguyen TT, Filloux C, and Van Obberghen E. Nerve growth factor-induced phosphorylation cascade in PC12 pheochromocytoma cells. Association of S6 kinase II with the microtubule-associated protein kinase, ERK1. J Biol Chem 267: 17369-17374, 1992.
23. Seta K, Nanamori M, Modrall JG, Neubig RR, and Sadoshima J. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem 277: 9268-9277, 2002.
24. Shah BH, Farshori MP, Jambusaria A, and Catt KJ. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J Biol Chem 278: 19118-19126, 2003.
25. Smith JA, Poteet-Smith CE, Malarkey K, and Sturgill TW. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274: 2893-2898, 1999.
26. Smith JA, Poteet-Smith CE, Xu Y, Errington TM, Hecht SM, and Lannigan DA. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res 65: 1027-1034, 2005.
27. Sturgill TW, Ray LB, Erikson E, and Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334: 715-718, 1988.
28. Touyz RM, He G, Wu XH, Park JB, Mabrouk ME, and Schiffrin EL. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 38: 56-64, 2001.
29. Treisman R, Marais R, and Wynne J. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J 11: 4631-4640, 1992.
30. Uemura H, Nakaigawa N, Ishiguro H, and Kubota Y. Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer. Curr Cancer Drug Targets 5: 307-323, 2005.
31. Xu Q, Liu Y, Gorospe M, Udelsman R, and Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 97: 508-514, 1996.
32. Yamazaki T, Komuro I, Shiojima I, and Yazaki Y. Angiotensin II mediates mechanical stress-induced cardiac hypertrophy. Diabetes Res Clin Pract 30, Suppl: 107-111, 1996.
33. Zhao Y, Bjorbaek C, and Moller DE. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases. J Biol Chem 271: 29773-29779, 1996.
34. Zhao Y, Bjorbaek C, Weremowicz S, Morton CC, and Moller DE. RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol 15: 4353-4363, 1995.